|
|
|
Volumn 41, Issue 4, 1999, Pages 219-231
|
|
Pharmacotherapy in people with learning disabilities; a dimensional approach;Farmacotherapie bij verstandelijk gehandicapten met gedragsstoornissen en/of psychiatrische aandoeningen. Een dimensionele benadering
|
|
Author keywords
Endorphins; Functional psychopharmacology; Mental retardation; Serotonin; Side effects
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CLOMIPRAMINE;
FLUOXETINE;
MIRTAZAPINE;
MOCLOBEMIDE;
NADOLOL;
NALTREXONE;
NEUROLEPTIC AGENT;
OPIATE ANTAGONIST;
PAROXETINE;
PROPRANOLOL;
SEROTONIN RECEPTOR AFFECTING AGENT;
SERTRALINE;
TRAZODONE;
VENLAFAXINE;
ARTICLE;
DRUG EFFICACY;
ELECTROLYTE DISTURBANCE;
EXTRAPYRAMIDAL SYMPTOM;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IMPULSIVENESS;
LEARNING DISORDER;
MAJOR CLINICAL STUDY;
MEDICAL RESEARCH;
MENTAL DETERIORATION;
MOOD;
PATHOGENESIS;
PSYCHOPHARMACOLOGY;
SEROTONIN SYNDROME;
SOCIAL ADAPTATION;
TREATMENT INDICATION;
|
|
EID: 0033009085
PISSN: 03037339
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (67)
|
